Umicore is one of the largest producers of platinum APIs for anti-cancer treatment. We pride ourselves in having decades of experience in platinum group metals chemistry and high potency APIs.
Umicore has been producing and marketing high potency Active Pharmaceutical Ingredients (hAPIs) for more than 20 years – complying with cGMP requirements, ICH guidelines and all applicable regulations in the pharmaceutical industry.
Our product portfolio does not only include:
» Cisplatin
» Carboplatin
» Oxaliplatin
but also various exclusive metal-based hAPIs.
Today, our technological expertise includes:
» Chemical synthesis of highly potent APIs
» Inorganic, organic and metal-organic chemistry
» R&D in high containment facilities: isolators, laminar-flow boxes
» Process and product handling under highly inert atmosphere
» Handling of high purity products and pyrophoric materials
» Expertise in analytical method development as well as in process and method validation
Working with us makes you benefit from:
» Professional and dedicated project management
» Full support from pre-clinical to commercial phase, including tech-transfer to our cGMP production facility in Argentina
» Strict protection of your IP
» Expertise in global IP strategy
» Close cooperation with our regulatory affairs department
At Umicore our values are transparent: teamwork, respect, openness, innovation and commitment, as well as trust and reliability reflect our basic business principles. Contact us to see for yourself.
Contact Details :
Umicore
Website: www.chemistry.umicore.com/api
E-mail: api@umicore.com
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.